Raymed Labs Limited Share Price

Equities

RAYLA

INE741C01017

Market Closed - Bombay S.E. 03:30:56 21/05/2024 pm IST 5-day change 1st Jan Change
2.39 INR 0.00% Intraday chart for Raymed Labs Limited 0.00% -2.85%
Sales 2022 - Sales 2023 - Capitalization 8.72M 724M
Net income 2022 - 0 Net income 2023 -1M -83.06M EV / Sales 2022 -
Net Debt 2022 493K 40.95M Net Debt 2023 495K 41.07M EV / Sales 2023 -
P/E ratio 2022
-8.23 x
P/E ratio 2023
-5.1 x
Employees 3
Yield 2022 *
-
Yield 2023
-
Free-Float 0%
More Fundamentals * Assessed data
Dynamic Chart
Raymed Labs Limited Announces Change in Registered Office Address CI
Raymed Labs Limited Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2023 CI
Raymed Labs Limited Reports Earnings Results for the Second Quarter and Six Months Ended September 30, 2023 CI
Raymed Labs Limited Reports Earnings Results for the First Quarter Ended June 30, 2023 CI
Raymed Labs Limited Reports Earnings Results for the Full Year Ended March 31, 2023 CI
Raymed Labs Limited Reports Earnings Results for the Fourth Quarter Ended March 31, 2023 CI
Raymed Labs Limited Announces Appointment of Shreya Dave as Company Secretary and Compliance Officer CI
Raymed Labs Limited Announces Resignation of Priyanka Sisodia as Company Secretary and Compliance Officer CI
Raymed Labs Limited Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2022 CI
Raymed Labs Limited Reports Earnings Results for the Second Quarter and Six Months Ended September 30, 2022 CI
Raymed Labs Limited Auditor Raises 'Going Concern' Doubt CI
Raymed Labs Limited Appoints Ajai Goyal as Chief Financial Officer CI
Raymed Labs Limited Reports Earnings Results for the First Quarter Ended June 30, 2022 CI
Raymed Labs Limited Reports Earnings Results for the Full Year Ended March 31, 2022 CI
Raymed Labs Limited Reports Earnings Results for the Fourth Quarter Ended March 31, 2022 CI
More news
3 months+7.66%
6 months-2.85%
Current year-2.85%
More quotes
1 week
2.39
Extreme 2.39
2.39
1 month
2.39
Extreme 2.39
2.39
Current year
2.08
Extreme 2.08
2.46
1 year
2.04
Extreme 2.04
2.46
3 years
0.92
Extreme 0.92
2.46
5 years
0.92
Extreme 0.92
2.89
10 years
0.92
Extreme 0.92
13.75
More quotes
Managers TitleAgeSince
Director of Finance/CFO - 13/02/13
Compliance Officer - 03/23/03
Director/Board Member 66 13/02/13
Members of the board TitleAgeSince
Director of Finance/CFO - 13/02/13
Director/Board Member 66 13/02/13
Director/Board Member - 25/15/25
More insiders
Date Price Change Volume

Delayed Quote Bombay S.E., May 21, 2024 at 03:30 pm IST

More quotes